Aduro Biotech IPO priced at $17 per share

April 14, 2015 9:46 PM

57 0

April 14 (Reuters) - Aduro Biotech Inc's initial public offering has been priced at $17 per share, an underwriter said, valuing the cancer immunotherapy drug developer at about $1 billion.

The upsized offering, which was priced on par with the company's expectation, raised about $119 million.

Also read: China Resources Pharma to raise $1.8 bln after pricing HK IPO near middle: IFR

Read more

To category page